ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer

N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer

(2015) Dorothee Pflueger et al.   NEOPLASIA

Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

(2015) Kyung Park et al.   NEOPLASIA

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ERG Protein Expression in Diagnostic Specimens Is Associated with Increased Risk of Progression During Active Surveillance for Prostate Cancer

(2014) Kasper Drimer Berg et al.   EUROPEAN UROLOGY

Active surveillance for clinically localized prostate cancer--A systematic review

(2014) Frederik B. Thomsen et al.   JOURNAL OF SURGICAL ONCOLOGY

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers

(2014) Christina Hägglöf et al.   PLoS One

A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort

(2014) Maria A. Svensson et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study

(2013) D. W. Lin et al.   CLINICAL CANCER RESEARCH

Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer

(2013) Kirsten D. Mertz et al.   HUMAN PATHOLOGY

Recurrent Gene Fusions in Prostate Cancer: Their Clinical Implications and Uses

(2013) Daphne Hessels et al.   Current Urology Reports

Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study

(2012) Jennifer R. Rider et al.   EUROPEAN UROLOGY

Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer

(2012) Gisele H.J.M. Leyten et al.   EUROPEAN UROLOGY

Chemical castration and anti-androgens induce differential gene expression in prostate cancer

(2012) Saara Lehmusvaara et al.   JOURNAL OF PATHOLOGY

Marked heterogeneity of ERG expression in large primary prostate cancers

(2012) Sarah Minner et al.   MODERN PATHOLOGY

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies

(2012) M Braun et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas

(2011) Alcides Chaux et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy

(2011) Sarah Minner et al.   CLINICAL CANCER RESEARCH

Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer

(2011) Martin Braun et al.   HISTOPATHOLOGY

Handling of radical prostatectomy specimens: total or partial embedding?

(2011) Ben Vainer et al.   HISTOPATHOLOGY

Common Gene Rearrangements in Prostate Cancer

(2011) Mark A. Rubin et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas

(2011) Antoun Toubaji et al.   MODERN PATHOLOGY

ERG gene rearrangement status in prostate cancer detected by immunohistochemistry

(2011) Sara Moscovita Falzarano et al.   VIRCHOWS ARCHIV

ERG rearrangement is present in a subset of transition zone prostatic tumors

(2010) Sara M Falzarano et al.   MODERN PATHOLOGY

Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort

(2010) Raquel Esgueva et al.   MODERN PATHOLOGY